# US 2004/0073197 A1 · Selective peripheral nerve plexus implantable infusion device and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0073197 A1
- Document ID: US20040073197A1
- Status: Published application
- Kind: A1
- Application number: 10/616,247
- Filed: 2003-07-09
- Published: 2004-04-15
- Earliest claimed: 2002-07-09
- Inventors: Philip S. Kim
- Web page: https://patentgrep.com/patent/US20040073197A1

## CPC

- A61M 5/14276: {specially adapted for implantation}
- A61M 2202/048: Anaesthetics
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The present invention relates to a closed system and method for selectively infusing anesthetics into a peripheral nerve or plexus. A method of providing long term pain management is disclosed herein. In the method, a catheter is surgically implanted to create an infusion site at a peripheral neural structure. An implantable pump and reservoir are surgically implanted in subcutaneous tissue. The pump is then operated to deliver a predetermined dosage of medication through the catheter into the infusion site, whereby pain management is provided.

## Claims

### Claim 1

A method providing long term pain management, the method comprising the steps of:
surgically implanting a catheter to create an infusion site, wherein a discharge portion of the catheter lies in a peripheral neural structure;
surgically implanting an implantable pump and reservoir in subcutaneous tissue, wherein a proximal end of the catheter, and the reservoir, are in communication with the pump; and
operating the pump to deliver a predetermined dosage of medication through the discharge portion of the catheter into the infusion site, whereby pain management is provided.

### Claim 2 (depends on 1)

The method of claim 1, wherein the neural structure is a brachial plexus nerve complex.

### Claim 3 (depends on 2)

The method of claim 2, wherein the catheter is implanted using an axillary approach.

### Claim 4 (depends on 2)

The method of claim 2, wherein the catheter is implanted using a subclavian, interscalene or infraclavicular approach.

### Claim 5 (depends on 2)

The method of claim 2, wherein implanting the catheter comprises the steps of:
placing a bore needle in communication with a grounding wire of a nerve stimulator;
inserting the bore needle within a facial sheath of the brachial plexus;
stimulating the bore needle to verify adequate placement within the facial sheath;
inserting an arterial line wire through the bore needle;
stimulating the arterial line to verify arterial line location adjacent to the brachial plexus; and
advancing the catheter over the arterial line and removing the arterial line.

### Claim 6 (depends on 5)

The method of claim 5, wherein implanting the pump and reservoir further comprises the steps of:
making a first incision in skin and subcutaneous tissue at an arterial line skin penetration location;
making a second incision, creating a subcutaneous pocket, and inserting the pump into the pocket;
creating a subcutaneous tunnel between the pocket and the first incision; and
threading the catheter through the subcutaneous tunnel to the pocket and attaching the catheter to the pump.

### Claim 7 (depends on 5)

The method of claim 5, wherein the bore needle has a conductive protrusion located at a base thereof and extending therefrom to create an angle therebetween to facilitate attachment to the grounding wire of the nerve stimulator.

### Claim 8 (depends on 1)

The method of claim 1, wherein the neural structure is a gasserian ganglion, a nasociliary nerve, a long ciliary nerve, an anterior ethmoidal nerve, a subraorbital nerve, a supratrochlear nerve, a maxillary nerve, an infraorbital nerve, a sphenopalantine nerve, a mandibular nerve, an inferior alveolar nerve, a lingual nerve, an auriculotemporal nerve, a masseter nerve or a mental nerve.

### Claim 9 (depends on 1)

The method of claim 1, wherein the neural structure is a cervical plexus, a greater occipital nerve, a lesser occipital nerve, a greater auricular nerve, a stellate ganglion or a glassopharyngeal nerve.

### Claim 10 (depends on 1)

The method of claim 1, wherein the neural structure is a brachial plexus with the catheter implanted using an interscalene approach, a brachial plexus with the catheter implanted using a supraclavicular approach, a brachial plexus with the catheter implanted using an infraclavicular approach, a brachial plexus with the catheter implanted using an axillary approach, a radial nerve, a median nerve, an ulnar nerve or a digital nerve.

### Claim 11 (depends on 1)

The method of claim 1, wherein the neural structure is a splanchnic nerve, a thoracic sympathetic ganglion or an intercostal nerve.

### Claim 12 (depends on 1)

The method of claim 1, wherein the neural structure is a lumbar sympathetic ganglion, a celiac plexus, an ilioinguinal nerve, an iliohypogastric nerve or a genitofemoral nerve.

### Claim 13 (depends on 1)

The method of claim 1, wherein the neural structure is a sciatic nerve, a femoral nerve, a lateral femoral cutaneous nerve, an obturator nerve, a common peroneal nerve, a saphanous nerve, a tibial nerve, a deep peroneal nerve, a superficial peroneal nerve, a superficial saphaneous nerve or a superficial sural nerve.

### Claim 14 (depends on 1)

The method of claim 1, wherein the catheter is lined with a metal strip conducive to electrical conduction.

### Claim 15 (depends on 14)

The method of claim 14, wherein the metal strip is stimulated to verify adequate catheter placement adjacent to the neural structure.

### Claim 16 (depends on 1)

The method of claim 1, wherein the medication is selected from the group consisting of bupivacaine, tetracaine and lidocaine.

### Claim 17 (depends on 1)

The method of claim 1, wherein the medication is selected from the group consisting of opiods, antispasmodics, alpha 2 agonists and local anesthetics.

### Claim 18 (depends on 1)

The method of claim 1, wherein the neural structure is in a thoracic region.

### Claim 19 (depends on 1)

The method of claim 1, wherein the neural structure is an intercostal, interpleural, or paravertebral nerve complex.

### Claim 20 (depends on 19)

The method of claim 19, wherein implanting the catheter comprises the steps of:
inserting a bore needle into skin and contacting a transverse process;
walking the bore needle cephalad off a superior boarder of the transverse process;
inserting the bore needle through a superior costotransverse ligament and into the paravertebral space; and
advancing the catheter through the bore needle and into the paravertebral space.

### Claim 21 (depends on 1)

The method of claim 1, wherein the neural structure is peripheral to a central nervous system.

### Claim 22

A closed system providing long term pain management, comprising:
a surgically implanted catheter having a discharge portion lying in a neural structure peripheral to a central nervous system; and
an implantable pump and reservoir located in subcutaneous tissue, wherein a proximal end of the catheter, and the reservoir, are in communication with the pump and the pump is operated to deliver a predetermined dosage of medication through the discharge portion of the catheter into the peripheral neural structure, thereby alleviating pain and providing pain management.

### Claim 23 (depends on 22)

The system of claim 22, wherein the medication is one of an opioid, antispasmodic, alpha 2 agonist or local anesthetic.

### Claim 24 (depends on 22)

The system of claim 22, wherein the medication is selected from the group consisting of an opioid, antispasmodic, alpha 2 agonist and a local anesthetic.

### Claim 25 (depends on 22)

The system of claim 22, wherein the medication is a combination of tetracaine, clonidine and baclofen.

### Claim 26 (depends on 25)

The system of claim 25, wherein the predetermined dosage of medication is approximately between 10-25 mg/day of tetracaine, approximately between 50-100 mcg/day of clonidine, and approximately between 50-100 mcg/day of baclofen.

### Claim 27 (depends on 22)

The system of claim 22, where the catheter has an embedded and electrically conductive material throughout the catheter length sufficient to enable electrical conduction, the material facilitating stimulation to verify a catheter distal end location adjacent to the neural structure.

### Claim 28

A surgical needle for use in inserting a catheter, comprising:
an electrically conductive shaft having a first end adapted to enter a facial sheath of a neural structure, a second end, wherein the shaft has an interior channel running longitudinally therethrough; and
an electrically conductive protrusion extending from the shaft to create a corner therebetween, the protrusion facilitating connection of the needle to a nerve stimulator.

### Claim 29 (depends on 28)

The surgical needle of claim 28, wherein the protrusion is adapted to be operatively connected to a clip located at a distal end of a grounding wire of a nerve stimulator.
